Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177803 | SCV000229737 | uncertain significance | not provided | 2014-06-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000356019 | SCV000470816 | likely benign | Cohen syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Ambry Genetics | RCV002317039 | SCV000850716 | uncertain significance | Inborn genetic diseases | 2017-05-31 | criteria provided, single submitter | clinical testing | The p.R1939Q variant (also known as c.5816G>A), located in coding exon 33 of the VPS13B gene, results from a G to A substitution at nucleotide position 5816. The arginine at codon 1939 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000356019 | SCV001013502 | likely benign | Cohen syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Molecular Endocrinology Laboratory, |
RCV000356019 | SCV002073507 | uncertain significance | Cohen syndrome | criteria provided, single submitter | clinical testing | ||
Prevention |
RCV003947507 | SCV004765988 | likely benign | VPS13B-related disorder | 2019-12-31 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ce |
RCV000177803 | SCV005051621 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | VPS13B: BS2 |